Appetite for weight-loss deals broader than visible, Viking CEO says

Core Insights - The CEO of Viking Therapeutics highlighted that the strategic interest in weight-loss drug deals is more extensive than it seems, indicating a growing market potential [1] Industry Overview - The weight-loss drug market is projected to reach a potential value of $150 billion, attracting significant attention from various drugmakers [1]